Has anyone seen tendon repair or regeneration using Spooky2 programs?

Perhaps the peptide presets Ankle Tendinitis:
Ankle tendinitis, frequently referring to Achilles tendinopathy or inflammation/degeneration of other ankle tendons (e.g., peroneal or tibial), is a common overuse injury characterized by pain, swelling, stiffness, and impaired function in the affected tendon. It predominantly arises from repetitive mechanical stress, leading to microtrauma, failed healing responses, and progressive degeneration rather than acute inflammation. Causes include excessive loading (e.g., running, jumping), poor biomechanics, inadequate recovery, age-related changes, and extrinsic factors like improper footwear. Pathophysiology involves tenocyte dysfunction, disrupted collagen homeostasis, low-grade chronic inflammation, aberrant neovascularization accompanied by nerve ingrowth (contributing to pain), and oxidative stress, resulting in tendon thickening, nodule formation, and reduced load-bearing capacity that can significantly limit mobility and athletic performance.
The proposed polypeptides target key therapeutic axes identified in the pathophysiology of ankle tendinitis, focusing on regeneration deficits, matrix dysregulation, inflammatory signaling, and cellular migration impairments. Each axis is addressed explicitly as follows:
1. Promotion of tendon healing and regeneration: BPC-157 (real-world pentadecapeptide with extensive preclinical evidence in rat models of Achilles tendon injury, accelerating outgrowth, cell survival, and functional recovery via endothelial protection and growth factor-like effects) directly enhances tendon repair; no additional designed for this axis, as real-world coverage is robust.
2. Enhancement of cell migration and actin dynamics: Thymosin β-4 (real-world endogenous peptide with documented preclinical promotion of tenocyte migration, anti-apoptosis, and actin sequestration in tendon healing models, often N-acetylated for stability) supports cellular repopulation and remodeling in degenerated tendons.
3. Inhibition of excessive extracellular matrix degradation: The CTTHWGFTLC-cyclic designed peptide (derived from an established selective MMP-2/9 inhibitory motif in literature, cyclized via disulfide with N-acetylation and C-amidation for protease resistance and prolonged joint retention) prevents collagen breakdown and preserves tendon structure.
4. Suppression of pro-inflammatory signaling: The NBD-inspired designed peptide (based on a validated NEMO-binding domain motif that blocks NF-κB activation, with N-acetylation and C-amidation for enhanced stability and bioavailability) attenuates cytokine-driven low-grade inflammation in the tendon microenvironment.
These polypeptides provide comprehensive multi-axis coverage, prioritizing real-world evidence for core regenerative mechanisms while employing rational, literature-derived designs with drug-likeness enhancements (short sequences, limited PTMs, cyclization/termini protection) for feasibility in potential local or systemic delivery, with low anticipated immunogenicity.

For more information, please click here: https://www.facebook.com/groups/spooky2/posts/3421182301376982